Gonadotropins for pubertal induction in males with hypogonadotropic hypogonadism: systematic review and meta-analysis
CONCLUSIONS: This systematic review provides convincing evidence of efficacy of gonadotropins for pubertal induction. However, there remains substantial heterogeneity in treatment choice, dose, duration, and outcomes assessed. Formal guidelines and randomised studies are needed.PMID:38128110 | DOI:10.1093/ejendo/lvad166 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 21, 2023 Category: Endocrinology Authors: Emma C Alexander Duaa Faruqi Robert Farquhar Ayesha Unadkat Kyla Ng Yin Rebecca Hoskyns Rachel Varughese Sasha R Howard Source Type: research

Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy
CONCLUSIONS: Diagnostic pathway in patients with genetic lipodystrophy is rendered difficult by the multisystemic features of the disease and the lack of knowledge of non-specialized physicians. Training physicians to systematically include adipose tissue examination in routine clinical evaluation should improve diagnosis and management of lipodystrophy and lipodystrophy-associated comorbidities.PMID:38128113 | DOI:10.1093/ejendo/lvad169 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 21, 2023 Category: Endocrinology Authors: H éléna Mosbah Camille Vatier B éatrice Andriss In ès Belalem Brigitte Delemer Sonja Janmaat Isabelle J éru Lauriane Le Collen Dominique Maiter Estelle Nob écourt Marie-Christine Vantyghem Network Pathologies Rares de l ’Insulino-Sécrétion et de Source Type: research

Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea (HISK)-based cohort study
CONCLUSION: This study suggests that the risk of breast cancer is increased by drugs in the CEPM group but not by tibolone, oral estrogen, CEPP, or topical estrogen. The mortality rate from breast cancer is lower with MHT (tibolone, CEPM, oral estrogen) than without MHT.PMID:38128117 | DOI:10.1093/ejendo/lvad168 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 21, 2023 Category: Endocrinology Authors: Jin-Sung Yuk Taeran Kim Hyunjin Cho Geumhee Gwak Source Type: research

Spleen function is reduced in individuals with NR5A1 variants with or without DSD: a cross-sectional study
CONCLUSIONS: Individuals harbouring a heterozygous NR5A1 variant that may cause DSD have a considerable risk for functional hyposplenism, irrespective of their gonadal phenotype. Splenic function should be assessed in these individuals, and if affected or unknown, prophylaxis is recommended to prevent invasive encapsulated bacterial infections. The splenic phenotype associated with NR5A1 variants is more severe in homozygous individuals and is, at least for the p.(Arg103Gln) variant, associated with asplenism.PMID:38128121 | DOI:10.1093/ejendo/lvad174 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 21, 2023 Category: Endocrinology Authors: Martine Cools Celien Grijp Jana Neirinck Simon J Tavernier Petra Schelstraete Julie Van De Velde Lieve Morb ée Elfride De Baere Carolien Bonroy Yolande van Bever Hennie Bruggenwirth Clementien Vermont Sabine E Hannema Yolanda De Rijke Maha Abdulhadi-Atwa Source Type: research

Pasireotide - potential treatment option for McCune Albright-associated acromegaly
Eur J Endocrinol. 2023 Dec 21:lvad173. doi: 10.1093/ejendo/lvad173. Online ahead of print.ABSTRACTOnly 30% of patients with McCune Albright syndrome (MAS)-associated acromegaly achieve biochemical control under first-generation somatostatin receptor ligands (fg-SRLs), while pegvisomant fails to normalize IGF-I in >20% of cases. Here, we report all the patients with MAS-associated acromegaly treated with pasireotide long-acting release (LAR) in our center. Pasireotide LAR 20 mg/month resulted in rapid and long-term insulin-like growth factor 1 (IGF-I) normalization in patient #1 and #3. Patient #3 was resistant to fg-SRL...
Source: European Journal of Endocrinology - December 21, 2023 Category: Endocrinology Authors: Mirela-Diana Ilie G érald Raverot Aude Brac de la Perri ère Source Type: research

A Novel Somatostatin Receptor Ligand for Human ACTH- and GH-secreting Pituitary Adenomas
Eur J Endocrinol. 2023 Dec 20:lvad171. doi: 10.1093/ejendo/lvad171. Online ahead of print.ABSTRACTSomatostatin receptor ligands have come to play a pivotal role in the treatment of both ACTH- and GH-secreting pituitary adenomas. Clinical efficacy averages 30-50%, thus a considerable number of patients with Cushing's disease or acromegaly remain unresponsive to this therapeutic approach. HTL0030310 is a new somatostatin receptor ligand selective for subtype 5 over subtype 2, thus with a different receptor profile compared to clinical somatostatin receptor ligands. The aim of the present study was to evaluate the effect of H...
Source: European Journal of Endocrinology - December 20, 2023 Category: Endocrinology Authors: Daniela Regazzo Serena Avallone Cliona P MacSweeney Eugenia Sergeev David Howe Alex Godwood Kirstie A Bennett Alastair J H Brown Matt Barnes Gianluca Occhi Mattia Barbot Diego Faggian Maria Pia Tropeano Marco Losa Giovanni Lasio Carla Scaroni Francesca Pe Source Type: research

Prolonged adrenal insufficiency following discontinuation of Osilodrostat treatment for intense hypercortisolism
We report two additional cases of persistent prolonged adrenal insufficiency after discontinuation of osilodrostat treatment for intense hypercortisolism due to Cushing's disease and ectopic ACTH syndrome. In addition, we show for that adrenal insufficiency in these patients was associated with low/normal 11-deoxycortisol concentrations despite high plasma ACTH concentrations. These results suggest that CYP11B1 is not the only target of osilodrostat and that, in vivo, osilodrostat has other prolonged and strong inhibitory effect on adrenal steroidogenesis upstream of CYP11B1. Knowledge of this remnant effect is important f...
Source: European Journal of Endocrinology - December 20, 2023 Category: Endocrinology Authors: A Ferriere S Salenave M Puerto J Young A Tabarin Source Type: research

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study
CONCLUSION: Without evidence-based withdrawal protocols, men commonly try avoiding post-AAS hypogonadism with PCT, which is illicit, ill-defined, and not recommended. Only half of men had complete biochemical testicular recovery after stopping AAS. The surprising association of self-reported PCT use with short-term biochemical recovery from AAS-induced hypogonadism warrants further investigation.PMID:38102386 | DOI:10.1093/ejendo/lvad164 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 15, 2023 Category: Endocrinology Authors: Bonnie Grant John Campbell Anjali Pradeep Angela D Burns Paul Bassett Ali Abbara Priyadarshi Saket Sukhbinder Minhas Waljit S Dhillo James McVeigh Shalender Bhasin Channa N Jayasena Source Type: research

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study
CONCLUSION: Without evidence-based withdrawal protocols, men commonly try avoiding post-AAS hypogonadism with PCT, which is illicit, ill-defined, and not recommended. Only half of men had complete biochemical testicular recovery after stopping AAS. The surprising association of self-reported PCT use with short-term biochemical recovery from AAS-induced hypogonadism warrants further investigation.PMID:38102386 | DOI:10.1093/ejendo/lvad164 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 15, 2023 Category: Endocrinology Authors: Bonnie Grant John Campbell Anjali Pradeep Angela D Burns Paul Bassett Ali Abbara Priyadarshi Saket Sukhbinder Minhas Waljit S Dhillo James McVeigh Shalender Bhasin Channa N Jayasena Source Type: research

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study
CONCLUSION: Without evidence-based withdrawal protocols, men commonly try avoiding post-AAS hypogonadism with PCT, which is illicit, ill-defined, and not recommended. Only half of men had complete biochemical testicular recovery after stopping AAS. The surprising association of self-reported PCT use with short-term biochemical recovery from AAS-induced hypogonadism warrants further investigation.PMID:38102386 | DOI:10.1093/ejendo/lvad164 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 15, 2023 Category: Endocrinology Authors: Bonnie Grant John Campbell Anjali Pradeep Angela D Burns Paul Bassett Ali Abbara Priyadarshi Saket Sukhbinder Minhas Waljit S Dhillo James McVeigh Shalender Bhasin Channa N Jayasena Source Type: research

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study
CONCLUSION: Without evidence-based withdrawal protocols, men commonly try avoiding post-AAS hypogonadism with PCT, which is illicit, ill-defined, and not recommended. Only half of men had complete biochemical testicular recovery after stopping AAS. The surprising association of self-reported PCT use with short-term biochemical recovery from AAS-induced hypogonadism warrants further investigation.PMID:38102386 | DOI:10.1093/ejendo/lvad164 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 15, 2023 Category: Endocrinology Authors: Bonnie Grant John Campbell Anjali Pradeep Angela D Burns Paul Bassett Ali Abbara Priyadarshi Saket Sukhbinder Minhas Waljit S Dhillo James McVeigh Shalender Bhasin Channa N Jayasena Source Type: research

Femora of Women with Premature Ovarian Insufficiency (POI) Exhibit Reduced Strength and Misalignment with the Transmitted Vertical Forces from the Upper Body
CONCLUSION: Alongside lower BMD at multiple sites, the femora of women with POI demonstrate reduced strength and a misalignment with forces transmitted from the upper body. Further research is needed to establish the role of these newly identified features and their role in fracture risk prediction in this population.PMID:38064575 | DOI:10.1093/ejendo/lvad158 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 8, 2023 Category: Endocrinology Authors: N Samad H H Nguyen Jasna Aleksova J A Pasco M A Kotowicz B J Strauss P R Ebeling A Vincent Roger Zebaze Frances Milat Source Type: research

Femora of Women with Premature Ovarian Insufficiency (POI) Exhibit Reduced Strength and Misalignment with the Transmitted Vertical Forces from the Upper Body
CONCLUSION: Alongside lower BMD at multiple sites, the femora of women with POI demonstrate reduced strength and a misalignment with forces transmitted from the upper body. Further research is needed to establish the role of these newly identified features and their role in fracture risk prediction in this population.PMID:38064575 | DOI:10.1093/ejendo/lvad158 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 8, 2023 Category: Endocrinology Authors: N Samad H H Nguyen Jasna Aleksova J A Pasco M A Kotowicz B J Strauss P R Ebeling A Vincent Roger Zebaze Frances Milat Source Type: research

Femora of Women with Premature Ovarian Insufficiency (POI) Exhibit Reduced Strength and Misalignment with the Transmitted Vertical Forces from the Upper Body
CONCLUSION: Alongside lower BMD at multiple sites, the femora of women with POI demonstrate reduced strength and a misalignment with forces transmitted from the upper body. Further research is needed to establish the role of these newly identified features and their role in fracture risk prediction in this population.PMID:38064575 | DOI:10.1093/ejendo/lvad158 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 8, 2023 Category: Endocrinology Authors: N Samad H H Nguyen Jasna Aleksova J A Pasco M A Kotowicz B J Strauss P R Ebeling A Vincent Roger Zebaze Frances Milat Source Type: research

Femora of Women with Premature Ovarian Insufficiency (POI) Exhibit Reduced Strength and Misalignment with the Transmitted Vertical Forces from the Upper Body
CONCLUSION: Alongside lower BMD at multiple sites, the femora of women with POI demonstrate reduced strength and a misalignment with forces transmitted from the upper body. Further research is needed to establish the role of these newly identified features and their role in fracture risk prediction in this population.PMID:38064575 | DOI:10.1093/ejendo/lvad158 (Source: European Journal of Endocrinology)
Source: European Journal of Endocrinology - December 8, 2023 Category: Endocrinology Authors: N Samad H H Nguyen Jasna Aleksova J A Pasco M A Kotowicz B J Strauss P R Ebeling A Vincent Roger Zebaze Frances Milat Source Type: research